Literature DB >> 20811374

The antibiotics market.

Bashar Hamad.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20811374     DOI： 10.1038/nrd3267

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

Review 1.  Why is big Pharma getting out of antibacterial drug discovery?

Authors:  Steven J Projan
Journal:  Curr Opin Microbiol       Date:  2003-10       Impact factor: 7.934

2.  Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE.

Authors:  Louis B Rice
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

3.  Biologics target bad bugs.

Authors:  Andy Extance
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694
  3 in total
  44 in total

1.  Patenting and the gender gap: should women be encouraged to patent more?

Authors:  Inmaculada de Melo-Martín
Journal:  Sci Eng Ethics       Date:  2012-01-03       Impact factor: 3.525

2.  β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates.

Authors:  Elizabeth Story-Roller; Christos Galanis; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  Synergistic Efficacy of β-Lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice.

Authors:  Elizabeth Story-Roller; Emily C Maggioncalda; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

4.  The political and ethical challenge of multi-drug resistant tuberculosis.

Authors:  Chris Degeling; Christopher Mayes; Wendy Lipworth; Ian Kerridge; Ross Upshur
Journal:  J Bioeth Inq       Date:  2015-01-29       Impact factor: 1.352

5.  Response to Fungal Dysbiosis by Gut-Resident CX3CR1+ Mononuclear Phagocytes Aggravates Allergic Airway Disease.

Authors:  Xin Li; Irina Leonardi; Alexa Semon; Itai Doron; Iris H Gao; Gregory Garbès Putzel; Youngjun Kim; Hiroki Kabata; David Artis; William D Fiers; Amanda E Ramer-Tait; Iliyan D Iliev
Journal:  Cell Host Microbe       Date:  2018-11-29       Impact factor: 21.023

6.  Rapid conversion of Pseudomonas aeruginosa to a spherical cell morphotype facilitates tolerance to carbapenems and penicillins but increases susceptibility to antimicrobial peptides.

Authors:  Leigh G Monahan; Lynne Turnbull; Sarah R Osvath; Debra Birch; Ian G Charles; Cynthia B Whitchurch
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

7.  Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.

Authors:  Chao-Dong Qian; Xue-Chang Wu; Yi Teng; Wen-Peng Zhao; Ou Li; Sheng-Guo Fang; Zhao-Hui Huang; Hai-Chun Gao
Journal:  Antimicrob Agents Chemother       Date:  2011-12-19       Impact factor: 5.191

8.  Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidines.

Authors:  Baskar Nammalwar; Christina R Bourne; Richard A Bunce; Nancy Wakeham; Philip C Bourne; Kal Ramnarayan; Shankari Mylvaganam; K Darrell Berlin; Esther W Barrow; William W Barrow
Journal:  ChemMedChem       Date:  2012-08-28       Impact factor: 3.466

9.  Retrospective surveillance of antibiotic use in maternity wards and neonatal intensive care units in Saint Petersburg, Russia.

Authors:  Timofey L Galankin; Alexey S Kolbin; Sergey V Sidorenko; Alexey A Kurylev; Elena A Malikova; Yuri V Lobzin; Dmitry O Ivanov; Nikolay P Shabalov; Anton V Mikhailov; Nikolay N Klimko; Gennadiy V Dolgov
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-21       Impact factor: 3.267

10.  Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.

Authors:  Mark W Majewski; Rohit Tiwari; Patricia A Miller; Sanghyun Cho; Scott G Franzblau; Marvin J Miller
Journal:  Bioorg Med Chem Lett       Date:  2016-02-27       Impact factor: 2.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.